Cancer Vaccine Development Program collaborations.
Mil Med
; 175(7 Suppl): 54-6, 2010 Jul.
Article
en En
| MEDLINE
| ID: mdl-23634481
ABSTRACT
Immunotherapy for cancer, which uses the body's immune system to fight the disease, is an increasingly active area of research. Successful therapies such as trastuzamab (Herceptin) for breast cancer and cytokine therapy for renal cell carcinoma and melanoma have validated the field as a viable area of investigation. However, the goal of developing an effective cancer vaccine has not yet been achieved. The military's Cancer Vaccine Development Program (CVDP) is collaborating with other military programs, along with civilian institutions, to advance scientific research surrounding cancer vaccines.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hospitales Urbanos
/
Vacunas contra el Cáncer
/
Asociación entre el Sector Público-Privado
/
Hospitales Militares
/
Hospitales Universitarios
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Mil Med
Año:
2010
Tipo del documento:
Article
País de afiliación:
Estados Unidos